NYSE American - Delayed Quote USD

Xtant Medical Holdings, Inc. (XTNT)

0.9015 +0.0115 (+1.29%)
At close: 3:59 PM EDT
0.9200 +0.02 (+2.05%)
After hours: 4:42 PM EDT
Loading Chart for XTNT
DELL
  • Previous Close 0.8900
  • Open 0.8861
  • Bid 0.8704 x 900
  • Ask 0.9340 x 1200
  • Day's Range 0.8751 - 0.9400
  • 52 Week Range 0.6000 - 1.4500
  • Volume 18,353
  • Avg. Volume 156,079
  • Market Cap (intraday) 117.391M
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) 90.15
  • EPS (TTM) 0.0100
  • Earnings Date May 2, 2024 - May 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.93

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.

www.xtantmedical.com

207

Full Time Employees

December 31

Fiscal Year Ends

Recent News: XTNT

Performance Overview: XTNT

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

XTNT
20.22%
S&P 500
5.84%

1-Year Return

XTNT
47.79%
S&P 500
22.03%

3-Year Return

XTNT
55.59%
S&P 500
20.77%

5-Year Return

XTNT
69.13%
S&P 500
72.46%

Compare To: XTNT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: XTNT

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    115.89M

  • Enterprise Value

    133.74M

  • Trailing P/E

    89.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.24

  • Price/Book (mrq)

    2.26

  • Enterprise Value/Revenue

    1.46

  • Enterprise Value/EBITDA

    26.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.72%

  • Return on Assets (ttm)

    -8.31%

  • Return on Equity (ttm)

    1.54%

  • Revenue (ttm)

    91.3M

  • Net Income Avi to Common (ttm)

    660k

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.71M

  • Total Debt/Equity (mrq)

    45.88%

  • Levered Free Cash Flow (ttm)

    -25.38M

Research Analysis: XTNT

Analyst Price Targets

1.85
1.93 Average
0.9015 Current
2.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: XTNT

Fair Value

0.9015 Current
 

Dividend Score

0 Low
XTNT
Sector Avg.
100 High
 

Hiring Score

0 Low
XTNT
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
XTNT
Sector Avg.
100 High
 

People Also Watch